Northern Alliance ATTC

We are delighted to share that the ATTC Network, co-ordinated by the CGT Catapult has received funding from the NIHR. This funding will allow continuation and enhancement of advanced therapy clinical trial initiatives. Here is the full story: ct.catapult.org.uk/news/17-9m-for…

Don’t miss this upcoming webinar hosted by the ATTC network on the 24 January 2024 at 1600 ‘Evaluation of the patient referral pathways for gene therapy and CAR-T in the UK’. Register here event.on24.com/wcc/r/4441182/…

In order to remain a life-sciences ‘superpower’ the UK needs to act now. The ‘Advanced Therapies Adoption Challenge in the United Kingdom’ report provides key recommendations to support action. theattcnetwork.co.uk/network/attcs-… #CellandGeneTherapy #AdvancedTherapies

Doing nothing is not an option in the field of Advanced Therapies. This report describes how the UK can retain its lead in the field. theattcnetwork.co.uk/network/attcs-… #CellandGeneTherapy #AdvancedTherapies

In Oct influential, knowledgeable and experienced minds met @RoySocMed in London to discuss barriers and develop solutions to the UK Advanced Therapies Adoption Challenge Read the report theattcnetwork.co.uk/network/attcs-…

In order to remain a life-sciences ‘superpower’ the UK needs to act now. The ‘Advanced Therapies Adoption Challenge in the United Kingdom’ report provides key recommendations to support action. theattcnetwork.co.uk/network/attcs-…

The future of access for patients to life changing advanced therapies lies in the hands of policy-makers and, in order to remain a life-sciences ‘superpower’, the UK needs to act now. bit.ly/46LxN5l #CellandGeneTherapy #AdvancedTherapies

ATMP Engage: ensuring patients are at the heart of ATMP delivery and research - register below for this webinar next Wed 8/12/23 hosted by the ATTC network. event.on24.com/wcc/r/4374097/…

@NewcastleHosps adopted a new labelling process (ISBT 128) in order to meet the most recent standards for apheresis products. attc-143fd.kxcdn.com/wp-content/upl…

We have concluded a joint, successful project with the DMD Hub (@UniofNewcastle) and the @CGTCatapult, which has resulted in a publication that analyses the gene therapy patient referral pathways in the UK. gbr01.safelinks.protection.outlook.com/?url=https%3A%…

Excited to be attending the 25th Communiqué awards with our clients @alderhey @CGTCatapult @GileadSciences. Good luck to all the finalists! @CxHealth #cxhealth

@UniofNewcastle will lead the administrative hub for this UK rare disease research platform, as well as being involved in two of the eleven nodes. Exciting opportunity for all involved.

Exciting to be part of this day run by the DMD Hub in Newcastle, looking at and agreeing the structure of gene therapy patient referral pathways.

Read all about the survey results led by our partner Autolus. The analysis looks at and evaluates the current landscape for electronic cell orchestration platforms. theattcnetwork.co.uk/uncategorized/…

Future best practice recommendations coming soon for CAR-T patient referral pathways ct.catapult.org.uk/news/new-colla…

Health Secretary @MathesonMichael has opened a new laboratory for cutting-edge work into potentially life-saving gene therapies in Edinburgh BioQuarter. The innovative work led @CGTCatapult will help ensure our healthcare systems are prepared for the future.

*New Publication* from our University of Manchester iMATCH team 🐝 Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy 👉 bitly.ws/G5dA

NEWS: SRPT today shared a program update related to SRP-9001. Read our press release: bit.ly/432xwKt

Our partners @Cytiva and @NHSBT have produced a document comparing liquid nitrogen and liquid nitrogen free controlled-rate freezing for the cryopreservation of MSCs. theattcnetwork.co.uk/news/cryoprese…